OpenPV Signal Explorer
FAERS disproportionality dashboard
Reaction

Pyelonephritis Acute reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 1,927 reports · 66 co-occurring drugs

As of the last recalculation, Pyelonephritis Acute appears in 1,927 FAERS reports alongside 66 co-occurring drug terms. The strongest observed disproportionality signal is BASILIXIMAB (PRR 24.2).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Basiliximab2624.224.2
Valganciclovir Hydrochloride Powder,2320.620.6
Anti-Thymocyte Globulin (Rabbit)1520.220.3
Everolimus Tablets2919.019.0
Mycophenilic Acid3518.618.6
Dimenhydrinate1818.418.4
Mycophenolic Acid4816.616.6
Mycophenolate Mofetil18416.116.1
Mycophenolate Mofetil Hydrochloride18416.016.1
Lanreotide Acetate1115.215.3
Valganciclovir2615.115.1
Valganciclovir Hydrochloride2615.115.1
Tacrolimus19414.814.8
Tacrolimus Ointment 0.1%14813.813.8
Tacrolimus Extended-Release Capsules14813.813.8
Ketoprofen1613.313.3
Lubiprostone1112.612.6
Loperamide Hydrochloride Oral1111.711.7
Piperacillin Sodium And Tazobactam Sodium2111.711.7
Baricitinib1011.311.3
Indapamide1810.911.0
Pitavastatin Calcium1010.610.6
Piperacillin And Tazobactam1210.210.2
Prednisolone1549.99.9
Prednisolone Oral1549.99.9
Prednisolone Oral Solution1549.99.9
Atazanavir139.89.8
Ceftriaxone Sodium349.79.7
Sirolimus129.79.7
Abiraterone129.69.6
Amphotericin B119.59.5
Loperamide Hcl119.39.3
Polyethylene Glycol99.09.0
Ceftriaxone268.78.7
Febuxostat Tablets 40 Mg88.58.5
Febuxostat Tablets 80 Mg88.58.5
Ganciclovir88.58.5
Entecavir98.48.4
Everolimus388.28.2
Ganciclovir Sodium88.28.2
Piperacillin Sodium,Tazobactam Sodium197.87.8
Abacavir Sulfate77.87.8
Dapagliflozin227.67.6
Meropenem217.17.1
Instalax Polyethylene Glycol 335087.07.0
Canagliflozin196.96.9
Polyethylene Glycol 40086.86.8
Tofacitinib Citrate86.66.6
Empagliflozin406.56.5
Brinzolamide56.26.2
Golimumab455.85.8
Fosaprepitant Dimeglumine75.55.5
Darbepoetin Alfa265.35.3
Ifosfamide105.05.1
Abiraterone Acetate195.05.0
Pemetrexed94.64.6
Palivizumab64.24.2
Methoxy Polyethylene Glycol-Epoetin Beta43.93.9
Atezolizumab143.93.9
Docetaxel Anhydrous243.93.9
Docetaxel243.93.9
Ribavirin223.73.7
Crizotinib43.43.4
Suvorexant43.33.3
Axicabtagene Ciloleucel33.33.3
Ixazomib72.62.6

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.